Infection-associated clozapine toxicity

Clinical Schizophrenia and Related Psychoses

Volumn 5, Issue 3, 2011, Pages 159-160

  Darling, Pam ^a   Huthwaite, Mark Arthur ^b  

^a CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Clozapine; Infection; Toxicity

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BENDROFLUMETHIAZIDE; BENZATROPINE; C REACTIVE PROTEIN; CITALOPRAM; CLOZAPINE; FELODIPINE; METOPROLOL; TRIMETHOPRIM; VALPROIC ACID; NEUROLEPTIC AGENT;

ADULT; AGITATION; ARTICLE; CASE REPORT; CONFUSION; COUGHING; DROWSINESS; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; ESCHERICHIA COLI; FEMALE; FEVER; HUMAN; HYPOTENSION; INFECTION; INSOMNIA; LETHARGY; LEUKOCYTE COUNT; MALE; NEUTROPHIL COUNT; RESPIRATION DEPRESSION; RESTLESSNESS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TACHYCARDIA; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; URINE INCONTINENCE; BACTERIAL PNEUMONIA; BLOOD; DRUG COMBINATION; ESCHERICHIA COLI INFECTION; METABOLISM; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; PSYCHOSIS;

ADULT; ANTIPSYCHOTIC AGENTS; C-REACTIVE PROTEIN; CLOZAPINE; DRUG THERAPY, COMBINATION; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; URINARY TRACT INFECTIONS;

EID: 84856365680     PISSN: 19351232     EISSN: None     Source Type: Journal    
DOI: 10.3371/CSRP.5.3.7     Document Type: Article

References (10)

1. Taylor DM, Douglas-Hall P, Olofinjana B, Whiskey E, Thomas A. Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection. Br J Psychiatry 2009;194(2):165-167.
2. Abdelmawla N, Ahmed MI. Clozapine and risk of pneumonia. Br J Psychiatry 2009;194(5):468-469.
3. Bertilsson L, Carrillo JA, Dahl ML, Lierena A, Alm C, Bondesson U, et al. Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test. Br J Clin Pharmacol 1994;38(5):471-473. (Pubitemid 24344037)
4. Linnet K, Olesen OV. Metabolism of clozapine by cDNA-expressed human cytochrome P450 enzymes. Drug Metab Dispos 1997;25(12):1379-1382. (Pubitemid 28010923)
5. Cormac I, Brown A, Creasey S, Ferriter M, Huckstep B. A retrospective evaluation of the impact of total smoking cessation on psychiatric inpatients taking clozapine. Acta Psychiatr Scand 2010;121(5):393-397.
6. Siewert E, Bort R, Kluge R, Heinrich PC, Castell J, Joyer R. Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent. Hepatology 2000;32(1):49-55. (Pubitemid 30432365)
7. de Leon J, Diaz FJ. Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report. Prog Neuropsychopharmacol Biol Psychiatry 2003;27(6):1059-1063. (Pubitemid 37141394)
8. Clozapine Datasheet. Novartis Pharmaceuticals Corporation. East Hanover, New Jersey. Rev: January 2010.
9. Haack MJ, Bak ML, Beurskens R, Maes M, Stolk LM, Delespaul PA. Toxic rise of clozapine plasma concentrations in relation to inflammation. Eur Neuropsychopharmacol 2003;13(5):381-385. (Pubitemid 37040921)
10. Raaska K, Raitasuo V, Arstila M, Neuvonen PJ. Bacterial pneumonia can increase serum concentration of clozapine. Eur J Clin Pharmacol 2002;58(5):321-322. (Pubitemid 34983922)